Marshall Wace’s ChipMOS TECHNOLOGIES IMOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
34,423
+1,820
+6% +$96.3K ﹤0.01% 1806
2026
Q1
$1.17M Buy
+32,603
New +$1.23M ﹤0.01% 2059
2023
Q2
Sell
-13,696
Closed -$344K 2686
2023
Q1
$344K Sell
13,696
-30,275
-69% -$708K ﹤0.01% 2248
2022
Q4
$942K Sell
43,971
-19,037
-30% -$391K ﹤0.01% 2118
2022
Q3
$1.17M Buy
+63,008
New +$1.42M ﹤0.01% 2334
2021
Q4
Sell
-5,963
Closed -$204K 4057
2021
Q3
$204K Buy
+5,963
New +$231K ﹤0.01% 2793
2017
Q1
Sell
-12,892
Closed -$214K 515
2016
Q4
$214K Sell
12,892
-45,221
-78% -$865K ﹤0.01% 919
2016
Q3
$1.27M Sell
58,113
-19,656
-25% -$406K 0.01% 684
2016
Q2
$1.55M Buy
77,769
+7,969
+11% +$157K 0.01% 641
2016
Q1
$1.34M Buy
+69,800
New +$1.34M 0.01% 645
2014
Q3
Sell
-82,782
Closed -$2.2M 949
2014
Q2
$2.2M Sell
82,782
-86,917
-51% -$2.19M 0.03% 384
2014
Q1
$4.13M Buy
+169,699
New +$3.88M 0.08% 255

Other funds holding IMOS

Marshall Wace's IMOS Position: Q2 2026 in Review

Marshall Wace increased its ChipMOS TECHNOLOGIES (IMOS) stake by 5.6% in Q2 2026, buying an estimated $96.3K and bringing the position to 34,423 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Marshall Wace first reported a position in IMOS in Q1 2014 and has held it in 12 quarters since. The position peaked at $4.13M in Q1 2014. 92 funds tracked by Wall St. Rank hold IMOS as of Q2 2026.

  • Marshall Wace held 34,423 shares of ChipMOS TECHNOLOGIES worth $2.21M as of Q2 2026.
  • Marshall Wace bought 1,820 ChipMOS TECHNOLOGIES shares in Q2 2026, an estimated $96.3K.
  • ChipMOS TECHNOLOGIES made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1806 holding.
  • Marshall Wace first reported a position in ChipMOS TECHNOLOGIES in Q1 2014 and has held it in 12 quarters since.
  • Marshall Wace's ChipMOS TECHNOLOGIES position peaked at $4.13M in Q1 2014.
  • 92 funds tracked by Wall St. Rank held ChipMOS TECHNOLOGIES as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.